In a new study published in Nature Medicine, they discovered how the levels of 16 molecules in the blood — all of which are ...
Kevan Shokat, PhD, a professor of Cellular and Molecular Pharmacology at UC San Francisco who discovered how to disable KRAS, ...
A new clinical trial will screen for atrial fibrillation (AFib) using a blood pressure monitor with AFib detection technology ...
A preliminary study led by UC San Francisco adds to growing evidence that reducing ultra-processed food may improve symptoms of depression. Published Sept. 23 in JAMA Psychiatry, the study, which is ...
From Machu Picchu to Mount Everest, people who live at high altitudes process sugar better and are less likely to develop ...
UC San Francisco researchers are weighing in on one of the biggest challenges in psychedelic science, arguing that clinical trials need more convincing placebo treatments to better measure the drugs’ ...
Invasive lobular carcinoma (ILC) is the second most common type of breast cancer but is challenging to detect because of how it spreads in breast tissue. ILC has been understudied compared to other ...